ORMP
NASDAQ · Pharmaceuticals
Oramed Pharmaceuticals Inc
$4.74
+0.07 (+1.50%)
Open$4.65
Previous Close$4.67
Day High$4.80
Day Low$4.61
52W High$5.47
52W Low$2.09
Volume—
Avg Volume158.7K
Market Cap193.84M
P/E Ratio1.11
EPS$4.13
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+101.5% upside
Current
$4.74
$4.74
Target
$9.55
$9.55
$5.95
$9.55 avg
$10.69
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.38M | 2.02M | 32.28M |
| Net Income | 63.35M | 58.29M | 5.51M |
| Profit Margin | 412.3% | 3,042.4% | 17.1% |
| EBITDA | -14,802,607 | -14,282,160 | 8.62M |
| Free Cash Flow | — | — | 3.23M |
| Rev Growth | — | -9.5% | +15.3% |
| Debt/Equity | — | — | 0.19 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |